3,4-dihydroxyphenylacetic acid has been researched along with u-50488 in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 9 (81.82) | 18.2507 |
2000's | 2 (18.18) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Althaus, JS; Donzanti, BA; Payson, MM; Von Voigtlander, PF | 1 |
Leyton, M; Rajabi, H; Stewart, J | 1 |
Lookingland, KJ; Manzanares, J; Moore, KE; Wagner, EJ | 1 |
Lookingland, KJ; Manzanares, J; Moore, KE | 2 |
Devine, DP; Leone, P; Pocock, D; Wise, RA | 1 |
Funada, M; Misawa, M; Nagase, H; Narita, M; Suzuki, T | 1 |
Durham, RA; Johnson, JD; Lookingland, KJ; Moore, KE | 1 |
Laorden, ML; Milanés, MV | 2 |
Chudapongse, N; Ho, IK; Kim, SY; Kramer, RE; Sasaki, K | 1 |
11 other study(ies) available for 3,4-dihydroxyphenylacetic acid and u-50488
Article | Year |
---|---|
Kappa agonist-induced reduction in dopamine release: site of action and tolerance.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; 3,4-Dihydroxyphenylacetic Acid; Analgesics; Animals; Dopamine; Drug Tolerance; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Nucleus Accumbens; Perfusion; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa | 1992 |
U-50,488H into A10 reduces haloperidol-induced elevations of accumbens dopamine.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; 3,4-Dihydroxyphenylacetic Acid; Analgesics; Animals; Dialysis; Dopamine; Haloperidol; Homovanillic Acid; Hydroxyindoleacetic Acid; Injections, Intraventricular; Male; Nucleus Accumbens; Pyrrolidines; Rats; Rats, Wistar | 1992 |
Effects of immunoneutralization of dynorphin1-17 and dynorphin1-8 on the activity of central dopaminergic neurons in the male rat.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; 3,4-Dihydroxyphenylacetic Acid; Analgesics; Animals; Brain Chemistry; Dopamine; Dynorphins; Injections, Intraventricular; Male; Median Eminence; Neurons; Peptide Fragments; Pyrrolidines; Rats | 1992 |
Kappa opioid receptor-mediated regulation of dopaminergic neurons in the rat brain.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; 3,4-Dihydroxyphenylacetic Acid; Analgesics; Animals; Brain; Dihydroxyphenylalanine; Male; Pyrrolidines; Rats; Receptors, Dopamine; Receptors, Opioid; Receptors, Opioid, kappa | 1991 |
Kappa-opioid-receptor-mediated regulation of alpha-melanocyte-stimulating hormone secretion and tuberohypophyseal dopaminergic neuronal activity.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; 3,4-Dihydroxyphenylacetic Acid; alpha-MSH; Animals; Apomorphine; Dihydroxyphenylalanine; Dopamine; Hypothalamo-Hypophyseal System; Male; Neurons; Pituitary Gland; Propranolol; Pyrrolidines; Radioimmunoassay; Rats; Receptors, Opioid; Receptors, Opioid, kappa | 1990 |
Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; 3,4-Dihydroxyphenylacetic Acid; Amino Acid Sequence; Analgesics; Animals; Chromatography, High Pressure Liquid; Corpus Striatum; Dialysis; Dopamine; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Homovanillic Acid; Hydroxyindoleacetic Acid; Limbic System; Male; Microinjections; Molecular Sequence Data; Naltrexone; Narcotic Antagonists; Pyrrolidines; Rats; Rats, Inbred Strains; Receptors, Opioid; Tegmentum Mesencephali | 1993 |
Blockade of morphine reward through the activation of kappa-opioid receptors in mice.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; 3,4-Dihydroxyphenylacetic Acid; Analgesics; Animals; Apomorphine; Conditioning, Operant; Dopamine; Dynorphins; Homovanillic Acid; Injections, Subcutaneous; Limbic System; Male; Mice; Mice, Inbred Strains; Morphine; Motivation; Naltrexone; Peptide Fragments; Prosencephalon; Pyrrolidines; Receptors, Opioid, kappa; Reward | 1993 |
Evidence that D2 receptor-mediated activation of hypothalamic tuberoinfundibular dopaminergic neurons in the male rat occurs via inhibition of tonically active afferent dynorphinergic neurons.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; 3,4-Dihydroxyphenylacetic Acid; Afferent Pathways; Analgesics; Animals; Cerebral Ventricles; Dihydroxyphenylalanine; Dopa Decarboxylase; Dopamine; Dopamine Agonists; Dynorphins; Hypothalamus; Hypothalamus, Middle; Injections, Intraperitoneal; Injections, Intraventricular; Limbic System; Male; Median Eminence; Naltrexone; Narcotic Antagonists; Neurons; Nucleus Accumbens; Prolactin; Pyrrolidines; Quinolines; Rats; Receptors, Dopamine D2; Receptors, Opioid, kappa | 1996 |
Effects of U-50,488H withdrawal on catecholaminergic neurones of the rat ventricle.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Heart Ventricles; Male; Naloxone; Neurons; Norepinephrine; Normetanephrine; Rats; Rats, Sprague-Dawley | 1998 |
Effects of U-50,488H and U-50,488H withdrawal on catecholaminergic neurons of the rat hypothalamus.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; 3,4-Dihydroxyphenylacetic Acid; Animals; Catecholamines; Corticosterone; Hypothalamus; Male; Methoxyhydroxyphenylglycol; Neurons; Norepinephrine; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Substance Withdrawal Syndrome; Weight Loss | 2000 |
Nonopioid receptor-mediated effects of U-50,488H on [Ca(2+)]i and extracellular dopamine in PC12 cells.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; 3,4-Dihydroxyphenylacetic Acid; Analgesics, Non-Narcotic; Analysis of Variance; Animals; Calcium; Dopamine; Dose-Response Relationship, Drug; Intracellular Fluid; Naltrexone; Narcotic Antagonists; PC12 Cells; Rats; Receptors, Opioid, kappa | 2003 |